2013
DOI: 10.1016/j.bmc.2013.10.032
|View full text |Cite
|
Sign up to set email alerts
|

The most effective influence of 17-(3-ethoxypropyl) substituent on the binding affinity and the agonistic activity in KNT-127 derivatives, δ opioid receptor agonists

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
11
0

Year Published

2014
2014
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 17 publications
(11 citation statements)
references
References 35 publications
0
11
0
Order By: Relevance
“…1), 14 and reported that these substitutions led to increased selectivities for the KOR or DOR, respectively, but decreased the binding affinities compared with the parent compounds. 10,15 The agonistic activities of 17-fluoroalkyl derivatives also decreased. 10,15 As our previous investigation dealt with agonists, we next attempted to apply these substitutions to DOR antagonist, naltrindole (NTI) 9,16 and compound 1.…”
mentioning
confidence: 94%
See 3 more Smart Citations
“…1), 14 and reported that these substitutions led to increased selectivities for the KOR or DOR, respectively, but decreased the binding affinities compared with the parent compounds. 10,15 The agonistic activities of 17-fluoroalkyl derivatives also decreased. 10,15 As our previous investigation dealt with agonists, we next attempted to apply these substitutions to DOR antagonist, naltrindole (NTI) 9,16 and compound 1.…”
mentioning
confidence: 94%
“…10,15 The agonistic activities of 17-fluoroalkyl derivatives also decreased. 10,15 As our previous investigation dealt with agonists, we next attempted to apply these substitutions to DOR antagonist, naltrindole (NTI) 9,16 and compound 1. 17 Herein, we report the synthesis of derivatives of NTI and compound 1 with the 17-fluoroethyl and 17-alkyl substituents, which were of similar size to the introduced fluorinated ethyl groups.…”
mentioning
confidence: 94%
See 2 more Smart Citations
“…179 Additional DOR agonists, for example conformationally constrained analogues of SNC-80, have been reported. 180 Mixed, bivalent, heteromeric and biased ligands These topics are beyond the scope of the present review, but they deserve mention and reference to recent reviews.…”
mentioning
confidence: 99%